Old Web
English
Sign In
Acemap
>
authorDetail
>
Sebastien Henriet
Sebastien Henriet
Cisplatin
Vinorelbine
Gemcitabine
Medicine
Oncology
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)
2021
Therapeutic Advances in Medical Oncology
Francesco Grossi
Piotr Jaśkiewicz
Marion Ferreira
Grzegorz Czyzewicz
Dariusz M. Kowalski
Libero Ciuffreda
Ramón García Gómez
Salvatore Caruso
Joaquim Bosch-Barrera
S. Gautier
Christine Ta Thanh Minh
Sebastien Henriet
Gilberto de Castro
Show All
Source
Cite
Save
Citations (0)
Randomized phase II trial of oral vinorelbine (OV) and cisplatin (P) followed by maintenance with single-agent OV versus (vs) gemcitabine (GEM) and P followed by maintenance with single-agent GEM as first-line chemotherapy (CT) in locally advanced (LA) or metastatic non-small-cell lung cancer (NSCLC) patients (pts) with squamous (sq) histological type.
2018
Journal of Clinical Oncology
Francesco Grossi
P. Jaskiewicz
Eric Pichon
Grzegorz Czyzewicz
Dariusz M. Kowalski
Libero Ciuffreda
Ramón García Gómez
Salvatore Caruso
Joaquim Bosch-Barrera
Christine Ta Thanh Minh
Sebastien Henriet
Stéphanie Gautier
Hélène Hervieu
Gilberto de Castro
Show All
Source
Cite
Save
Citations (0)
1